Lexaria Bioscience's market cap is currently $25.10M. The company's EPS TTM is $-0.489; its P/E ratio is ―; Lexaria Bioscience is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 24	Sep 23	Sep 22	Sep 21	Sep 20
Income Statement
Total Revenue	$ 464.28K	$ 226.21K	$ 255.40K	$ 722.74K	$ 384.54K
Gross Profit	$ 459.46K	$ 194.71K	$ 183.56K	$ 547.39K	$ 285.17K
Operating Income	$ -5.75M	$ -6.53M	$ -7.38M	$ -5.69M	$ -3.89M
EBITDA	$ -5.68M	$ -6.39M	$ -6.52M	$ -5.58M	$ -4.00M
Net Income	$ -5.80M	$ -6.66M	$ -7.27M	$ -2.50M	$ -4.03M
Balance Sheet
Cash & Short-Term Investments	$ 6.56M	$ 1.48M	$ 6.16M	$ 11.75M	$ 1.31M
Total Assets	$ 8.87M	$ 3.08M	$ 7.83M	$ 13.27M	$ 2.83M
Total Debt	$ 137.37K	$ 163.97K	$ 49.99K	$ 97.32K	$ 156.10K
Net Debt	$ -6.36M	$ -1.19M	$ -5.76M	$ -10.82M	$ -1.14M
Total Liabilities	$ 1.21M	$ 403.91K	$ 201.44K	$ 203.26K	$ 345.98K
Stockholders' Equity	$ 8.04M	$ 3.04M	$ 7.95M	$ 13.27M	$ 2.53M
Cash Flow
Free Cash Flow	$ -4.96M	$ -6.05M	$ -5.01M	$ -4.07M	$ -2.70M
Operating Cash Flow	$ -4.96M	$ -5.88M	$ -4.88M	$ -3.99M	$ -2.66M
Investing Cash Flow	$ -188.60K	$ -169.61K	$ -180.64K	$ 193.88K	$ -26.84K
Financing Cash Flow	$ 10.32M	$ 1.59M	$ -44.60K	$ 13.42M	$ 2.70M

Currency in USD

Lexaria Bioscience Earnings and Revenue History

Income Statement >

Lexaria Bioscience Debt to Assets

Balance Sheet >

Lexaria Bioscience Cash Flow

Cash Flow >

Lexaria Bioscience Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing